Under the terms of the merger agreement, Vallon will acquire 100% of the outstanding equity interests of GRI Bio, by means of reverse merger. The value of the deal is $49 million.
Under the terms of the merger agreement, Vallon will acquire 100% of the outstanding equity interests of GRI Bio, by means of reverse merger. The value of the deal is $49 million.
